Radiofrequency Ablation Devices Market To Experience A Hike In Growth By 2030: Market Research Future 2030
Radiofrequency Ablation Devices Market
Overview
Expanding geriatric population combined with
rising life expectancy could stimulate market growth. As older people are
highly susceptible to chronic diseases, the demand for effective treatment has
subsequently increased. This works in favor of the RF ablation market. The
World Health Organization (WHO) asserts that the global population aged 60
years and above could touch the valuation of 2 billion by 2050, which was 900
million in 2015. As the demographic generally has the highest disability rate,
it results in high demand for effective care and treatment, which backs the
market growth.
The surge in critical medical intervention is
predicted to enhance the radiofrequency ablation devices market. Reports
created by MRFR detail the developments of the industry that can be expected in
the market through the forecast period. The market is projected to record a
CAGR of 10.50% throughout the forecast period.The worldwide Radiofrequency Ablation Devices
Market gets a boost from the rising prevalence of
chronic and cardiovascular diseases. The preference for minimally invasive
surgeries also benefits the market to a great extent. The Centers for Disease
Control and Prevention (CDC) predicts that Atrial Fibrillation (AF) could
affect close to 17.9 million in Europe by the year 2060, in addition to
affecting 12 million people in the United States (U.S.) by the year 2050.
Mounting healthcare expenditure in light of the
rising number of diseases could have a significant impact on the market in the
coming years. Speaking of diseases, arthritis and osteoporosis have surged in
number in recent years, which led to considerable market growth. The U.S.
Department of Health & Human Services reported that in 2015, around 15
million adults suffered from extreme joint pain owing to arthritis. It added
that by the year 2040, roughly 78 million (26%) adults in the country of age 18
years and above are expected to be diagnosed with arthritis
Market Segmentation
The segments in the global radiofrequency ablation
devices market have been considered for type and application.
With respect to the type, the global
radiofrequency ablation devices market is segmented into unipolar
radiofrequency ablation and bipolar radiofrequency ablation.
Application-wise, the market covers cardiology and
cardiac rhythm management, surgical oncology, cosmetology, gynecology, pain
management, and others.
Regional Analysis
The geographical distribution of the
radiofrequency ablation devices market covers Asia Pacific, the Americas,
Middle East & Africa, and Europe.
The Americas leads the global market for
radiofrequency ablation devices as it notes a high number of lung cancer cases
such as Non-Small Cell Lung Cancer (NSCLC), one of the most common types of
lung cancer. Also, small cell lung cancer (SCLC) is witnessing growth in the
region. Therefore, with the surge in NSCLC and SCLC in recent years, the
regional market for radiofrequency ablation devices has scaled at a tremendous
rate.
In 2017, Europe was identified as the second most
prominent market for radiofrequency ablation devices. Europe shows high
resilience as well as leadership with respect to approving renal denervation
systems, where other regions are still skeptical of the clinical outcomes. This
factor helps the market gain momentum in the region. With the presence of
established RF technology companies along with more and more companies gaining
entry, the region could maintain its elite position in the years ahead as well.
Asia Pacific market is rising at the fastest-rate
in the worldwide market, as estimated by MRFR in 2017. Surging
awareness of cardiac diseases, expanding healthcare industries, and developing
treatment methods for gynecology and cosmetology have helped quicken the pace
of the regional market.
Taking into account the weak economy and low per
capita income, primarily in Africa, MRFR estimated Middle East and Africa as
the smallest market market. The larger portion of the market lies within Middle
East, with support from rising government funding for healthcare and presence
of developing economies such as Kuwait, the United Arabs Emirates (UAE), Dubai,
and others.
Esteemed Companies
Some of the esteemed companies in the
worldwide radiofrequency
ablation devices market Players include
AtriCure, Inc., Stryker, Cosman Medical, Inc., Angiodynamics, Smith &
Nephew, Medtronic Inc, Boston Scientific Corporation, RF Medical Co. Ltd,
Johnson & Johnson (J&J) Services, LLC, St. Jude Medical, and others
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
.jpg)
Comments
Post a Comment